Effect of Durvadi Taila and Povidone in Dustha Vrana

A Comparative Clinical Study of Durvadi Taila and Povidone Iodine in Dustha Vrana - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093151

Enrollment

Registered

2025-08-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from dushta vrana having clinical features like pricking and tearing type of pain foul smell pus discharge burning sensation itching were selected for the study Patients with wound size of less than 10cm 5cm 1cm Patients of either sex between the age group of 5 years and above Patients suffering from systemic diseases like uncontrolled diabetes mellitus tuberculosis etc will be include in the present study

Exclusion criteria

Exclusion criteria: Patients suffering from grave condition like malignant ulcer and other severe illeness like HIV HbsAg will be exclude Patients suffering from Dagdhavrana pressure ulcer Arterial ulcer Patients having pre gangrenous or gangrenous changes Patients suffering from osteomyelitis Vrana present on allmovable and highly movable joints Patients suffering from diabetic foot

Design outcomes

Primary

Measure	Time frame
Complete wound healingTimepoint: 1 month	—

Secondary

Measure	Time frame
Pain and Discharge reduction, Wound size reduction.Timepoint: 1 month	—

Countries

India

Contacts

Public ContactDr Kritika Sharma

Shri Babu Singh Jay Singh Ayurvedic Medical College and Hospital

ravivarma3856@gmail.com9036563856

Outcome results